Annie Darilay

422 total citations
12 papers, 317 citations indexed

About

Annie Darilay is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Annie Darilay has authored 12 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Annie Darilay's work include Advanced Breast Cancer Therapies (4 papers), HIV-related health complications and treatments (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Annie Darilay is often cited by papers focused on Advanced Breast Cancer Therapies (4 papers), HIV-related health complications and treatments (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Annie Darilay collaborates with scholars based in United States, United Kingdom and Japan. Annie Darilay's co-authors include Lisa P. Jacobson, Charles R. Rinaldo, Mallory D. Witt, Roger Detels, Chloe L. Thio, Eric C. Seaberg, Sheila Badri, Steve Young, J. Armstrong and Alejandra Negro and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Annie Darilay

12 papers receiving 310 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Annie Darilay United States	8	157	130	105	84	59	12	317
Adil Başkıran Türkiye	12	126 0.8×	49 0.4×	68 0.6×	28 0.3×	30 0.5×	42	310
Enrique L. Álvarez Spain	11	217 1.4×	87 0.7×	218 2.1×	65 0.8×	26 0.4×	29	403
Hesham Elghazaly Egypt	13	89 0.6×	56 0.4×	75 0.7×	30 0.4×	49 0.8×	29	331
Paulo Henrique Lima Brazil	5	50 0.3×	104 0.8×	155 1.5×	36 0.4×	15 0.3×	9	285
Lotte C. Dinesen United Kingdom	7	51 0.3×	136 1.0×	255 2.4×	32 0.4×	173 2.9×	11	623
ST Fan Hong Kong	9	303 1.9×	117 0.9×	102 1.0×	14 0.2×	121 2.1×	39	466
Tom Pembroke United Kingdom	10	120 0.8×	129 1.0×	137 1.3×	19 0.2×	31 0.5×	24	408
I‐Lun Shih Taiwan	12	54 0.3×	139 1.1×	84 0.8×	18 0.2×	100 1.7×	28	423
Mario Tamburini Italy	8	93 0.6×	189 1.5×	113 1.1×	58 0.7×	11 0.2×	11	360
Shee‐Chan Lin Taiwan	14	147 0.9×	86 0.7×	154 1.5×	21 0.3×	186 3.2×	39	575

Countries citing papers authored by Annie Darilay

Since Specialization

Citations

This map shows the geographic impact of Annie Darilay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annie Darilay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annie Darilay more than expected).

Fields of papers citing papers by Annie Darilay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annie Darilay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annie Darilay. The network helps show where Annie Darilay may publish in the future.

Co-authorship network of co-authors of Annie Darilay

This figure shows the co-authorship network connecting the top 25 collaborators of Annie Darilay. A scholar is included among the top collaborators of Annie Darilay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annie Darilay. Annie Darilay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Dent, Rebecca, J-Y Pierga, Caterina Marchiò, et al.. (2024). LBA21 Human epidermal growth factor receptor 2 (HER2)-low and HER2-ultralow status determination in tumors of patients (pts) with hormone receptor–positive (HR+) metastatic breast cancer (mBC) in DESTINY-Breast06 (DB-06). Annals of Oncology. 35. S1213–S1214. 7 indexed citations

André, Fabrice, Erika Hamilton, Sherene Loi, et al.. (2022). Dose-finding and -expansion studies of trastuzumab deruxtecan in combination with other anti-cancer agents in patients (pts) with advanced/metastatic HER2+ (DESTINY-Breast07 [DB-07]) and HER2-low (DESTINY-Breast08 [DB-08]) breast cancer (BC).. Journal of Clinical Oncology. 40(16_suppl). 3025–3025. 23 indexed citations

Ouwens, Mario, Annie Darilay, Yiduo Zhang, et al.. (2021). Assessing the Influence of Subsequent Immunotherapy on Overall Survival in Patients with Unresectable Stage III Non–Small Cell Lung Cancer from the PACIFIC Study. Current Therapeutic Research. 95. 100640–100640. 7 indexed citations

Bardia, Aditya, Carlos H. Barrios, Rebecca Dent, et al.. (2021). Abstract OT-03-09: Trastuzumab deruxtecan (T-DXd; DS-8201) vs investigator’s choice of chemotherapy in patients with hormone receptor-positive (HR+), HER2 low metastatic breast cancer whose disease has progressed on endocrine therapy in the metastatic setting: A randomized, global phase 3 trial (DESTINY-Breast06). Cancer Research. 81(4_Supplement). OT–3. 21 indexed citations

Jhaveri, Komal, Erika Hamilton, Sherene Loi, et al.. (2021). Abstract OT-03-05: Trastuzumab deruxtecan (T-DXd; DS-8201) in combination with other anticancer agents in patients with HER2-low metastatic breast cancer: A phase 1b, open-label, multicenter, dose-finding and dose-expansion study (DESTINY-Breast08). Cancer Research. 81(4_Supplement). OT–3. 8 indexed citations

Hansen, Ryan N., Yiduo Zhang, Brian Seal, et al.. (2020). Long-term survival trends in patients with unresectable stage III non-small cell lung cancer receiving chemotherapy and radiation therapy: a SEER cancer registry analysis. BMC Cancer. 20(1). 276–276. 23 indexed citations

Ouwens, Mario, Annie Darilay, P. Mukhopadhyay, et al.. (2019). Impact of subsequent post-discontinuation immunotherapy on overall survival in patients with unresectable, stage III NSCLC from PACIFIC. Annals of Oncology. 30. ii31–ii31. 1 indexed citations

Abou‐Alfa, Ghassan K., Stephen L. Chan, Junji Furuse, et al.. (2018). A randomized, multicenter phase 3 study of durvalumab (D) and tremelimumab (T) as first-line treatment in patients with unresectable hepatocellular carcinoma (HCC): HIMALAYA study.. Journal of Clinical Oncology. 36(15_suppl). TPS4144–TPS4144. 78 indexed citations

Roy, Sion, Michelle M. Estrella, Annie Darilay, et al.. (2016). Glomerular filtration rate and proteinuria associations with coronary artery calcium among HIV-infected and HIV-uninfected men in the Multicenter AIDS Cohort Study. Coronary Artery Disease. 28(1). 17–22. 6 indexed citations

10.

Abraham, Alison G., Annie Darilay, Heather McKay, et al.. (2015). Kidney Dysfunction and Markers of Inflammation in the Multicenter AIDS Cohort Study. The Journal of Infectious Diseases. 212(7). 1100–1110. 32 indexed citations

11.

Margolick, Joseph B., Lisa P. Jacobson, George J. Schwartz, et al.. (2014). Factors Affecting Glomerular Filtration Rate, as Measured by Iohexol Disappearance, in Men with or at Risk for HIV Infection. PLoS ONE. 9(2). e86311–e86311. 11 indexed citations

12.

Witt, Mallory D., Eric C. Seaberg, Annie Darilay, et al.. (2013). Incident Hepatitis C Virus Infection in Men Who Have Sex With Men: A Prospective Cohort Analysis, 1984-2011. Clinical Infectious Diseases. 57(1). 77–84. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact